Order Article Reprints

Hamdard J, Muğlu H, Bilici A, Kuzucular E, Açıkgöz Ö, Ölmez ÖF, Olmuşçelik O, Yıldız Ö. The Prognostic and Predictive Roles of Ataxia–Telangiectasia Mutated (ATM) Expression in Patients with Metastatic Non-Small-Cell Lung Cancer Receiving Pembrolizumab Monotherapy Alone or in Combination with Chemotherapy. Diagnostics. 2025; 15(8):1048. https://doi.org/10.3390/diagnostics15081048

Hamdard, Jamshid, Harun Muğlu, Ahmet Bilici, Elif Kuzucular, Özgür Açıkgöz, Ömer Fatih Ölmez, Oktay Olmuşçelik, and Özcan Yıldız. 2025. "The Prognostic and Predictive Roles of Ataxia–Telangiectasia Mutated (ATM) Expression in Patients with Metastatic Non-Small-Cell Lung Cancer Receiving Pembrolizumab Monotherapy Alone or in Combination with Chemotherapy" Diagnostics 15, no. 8: 1048. https://doi.org/10.3390/diagnostics15081048

Hamdard, J., Muğlu, H., Bilici, A., Kuzucular, E., Açıkgöz, Ö., Ölmez, Ö. F., Olmuşçelik, O., & Yıldız, Ö. (2025). The Prognostic and Predictive Roles of Ataxia–Telangiectasia Mutated (ATM) Expression in Patients with Metastatic Non-Small-Cell Lung Cancer Receiving Pembrolizumab Monotherapy Alone or in Combination with Chemotherapy. Diagnostics, 15(8), 1048. https://doi.org/10.3390/diagnostics15081048